.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Federal Trade Commission
Fuji
McKinsey
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Chubb
Baxter
Mallinckrodt

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021717

« Back to Dashboard
NDA 021717 describes PLIAGLIS, which is a drug marketed by Taro Pharms and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the PLIAGLIS profile page.

The generic ingredient in PLIAGLIS is lidocaine; tetracaine. There are twenty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the lidocaine; tetracaine profile page.

Summary for 021717

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 021717

Ingredient-typeAmides
Esters
Physiological EffectLocal Anesthesia

Suppliers and Packaging for NDA: 021717

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PLIAGLIS
lidocaine; tetracaine
CREAM;TOPICAL 021717 NDA Galderma Laboratories, L.P. 0299-6100 0299-6100-10 1 TUBE in 1 CARTON (0299-6100-10) > 100 g in 1 TUBE
PLIAGLIS
lidocaine; tetracaine
CREAM;TOPICAL 021717 NDA Galderma Laboratories, L.P. 0299-6100 0299-6100-30 1 TUBE in 1 CARTON (0299-6100-30) > 30 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength7%;7%
Approval Date:Jun 29, 2006TE:RLD:Yes
Patent:► SubscribePatent Expiration:Sep 28, 2019Product Flag?YSubstance Flag?Delist Request?

Expired Orange Book Patents for NDA: 021717

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Taro Pharms
PLIAGLIS
lidocaine; tetracaine
CREAM;TOPICAL021717-001Jun 29, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
AstraZeneca
Express Scripts
Deloitte
Julphar
Federal Trade Commission
Queensland Health
Fish and Richardson
Johnson and Johnson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot